je.st
news
Tag: phase
DEWA selects Masdar-led consortium for Al Maktoum Solar Park phase three
2016-06-29 01:00:00| Power Technology
The Dubai Electricity and Water Authority (DEWA) has selected Masdar-led consortium for the 800MW third phase of the $13.6bn Mohammed bin Rashid Al Maktoum Solar Park in Seih Al-Dahal.
PG&E to Phase Out Nuclear Power
2016-06-22 17:38:00| Transmission & Distribution World
PG&E has announced a joint proposal with labor and environmental organizations that would increase investment in energy efficiency, renewables and storage read more
DOE selects SiiLion for $1M SBIR Phase II award; ionic-liquid-enabled high-energy li-ion battery
2016-06-22 12:56:00| Green Car Congress
Pyrenees Phase Three Expansion
2016-06-21 01:00:00| Offshore Technology
The Pyrenees Development lies within permit areas WA-42-L and WA-43-L in water depths ranging from 190m to 260m.
Tags: phase
expansion
pyrenees
Results of Phase 2 Study of Mercks Investigational Beta-Lactamase Inhibitor Relebactam in Combination with Imipenem/Cilastatin Presented at ASM Microbe
2016-06-20 18:30:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. Pivotal Phase 3 Studies Ongoing in Treatment of Serious Bacterial Infections KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that a Phase 2 study of relebactam, the companys investigational beta-lactamase inhibitor, in combination with imipenem/cilastatin (an approved carbapenem antibiotic), in patients with complicated urinary tract infections, met its primary endpoint. Language: English Contact: MerckMedia:Pamela Eisele, (267) 305-3558orRobert Consalvo, (908) 295-0928orInvestor:Teri Loxam, (908) 740-1986orAmy Klug, (908) 740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: results
study
presented
combination
Sites : [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] next »